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Background  and  purpose.  –  Surgery  for  diffuse  low-grade  glioma  (DLGG)  was debated  for  a  long  time.
Discrepancies  in  the  classical  literature  are  mainly  due  to  the  lack  of  objective  radiological  assessment
of  the  extent  of  resection  (EOR).  Here,  the  goal  is to review  the recent  data  on  oncological  and  functional
outcomes.
Methods.  – Surgical  series  with  calculation  of EOR  on  postoperative  MRI  were  reviewed.
Results. – In all modern  series,  a  more  aggressive  resection  predicted  signiﬁcant  improvement  in overall
survival  (OS)  compared  with  a simple  debulking.  Especially,  an  extended  removal  of  a margin  beyond
the  MRI-deﬁned  abnormalities  (“supra-total”  resection)  signiﬁcantly  increased  OS  by  delaying  malig-
nant  transformation.  Furthermore,  advances  in  intraoperative  brain  mapping  techniques  resulted  in a
minimization  of neurological  deﬁcits.
Discussion/Conclusion. –  These  recent  data  strongly  argue  in  favor  of  achieving  a maximal  resection  of
DLGG  as  the  ﬁrst  therapeutic  option.  Biopsy  should  be considered  only  in very  diffuse  lesions  (gliomatosis)
or  when  a subtotal  resection  is not  a priori  possible.  Thus,  neurosurgeons  should  change  their  mind,  by
operating  the  brain  involved  by  a chronic  tumoral  disease  rather  than by  trying  to  remove  a  “tumor
mass”.  The  aim  is  not  to  achieve  a simple  “tumorectomy”,  but  the  most  extensive  resection  of the  brain
invaded  by  DLGG,  on  the condition  that  this  part  of  the  brain  is  not  crucial  for cerebral  functions.  This
new  philosophy  suggests  to perform  early  and  maximal  resection  according  to  functional  (and  not  purely
oncological  or  anatomical)  boundaries  in  awake  patients.  This  perspective  is the  best way  to  build  a
personalized  “functional  surgical  neuro-oncology”.
©  2012  Elsevier  Masson  SAS.  
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Objectif.  –  La chirurgie  des  gliomes  diffus  de  bas  grade  (GDBG)  a longtemps  été controversée.  Les
contradictions  dans  la  littérature  classique  sont  essentiellement  dues  au  manque  d’évaluation  radi-
ologique  objective  de  l’étendue  de la  résection  (ER).  Le  but  est  ici  de  passer  en  revue  les  données  récentes
concernant  les  résultats  fonctionnels  et oncologiques.
Open access under CC BY-NC-ND license.édianes de survie
tendue  d’exérèse
Méthode. – Les  séries  chirurgicales  avec  calcul  objectif  de  l’ER  sur  une  IRM  postopératoire  ont  été
analysées.artographie fonctionnelle
Résultats.  – Dans  toutes  les  séries  récentes,  une  résection  plus  extensive  était  associée  à une  majoration  de
la  survie  globale  en  comparaison  par  rapport  à  une  simple  biopsie  élargie.  En  particulier,  l’ablation  d’une
marge  au-delà  des  anomalies  IRM  (résection  « supra-totale ») a signiﬁcativement  augmenté  la  survie  en
retardant  la transformation  maligne.  De  plus,  l’avancée  des  techniques  de  cartographie  fonctionnelle
peropératoire  a  permis  une  minimisation  des  déﬁcits  neurologiques.
∗ Department of Neurosurgery, hôpital Gui-de-Chauliac, CHU de Montpellier, 80,
venue Augustin-Fliche, 34295 Montpellier, France.
E-mail address: h-duffau@chu-montpellier.fr
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Discussion/Conclusion.  –  Ces  données  récentes  plaident  en  faveur  d’une  chirurgie  maximaliste  comme
première option  thérapeutique  dans  les  GDBG.  Une  biopsie  ne  devrait  être  envisagée  que pour  les lésions
très diffuses  (gliomatoses)  ou lorsqu’une  exérèse  subtotale  n’est  a priori  pas  possible.  De  fait,  les  neu-
rochirurgiens devraient  changer  leur  état  d’esprit,  en  opérant  un  cerveau  inﬁltré  par  une  maladie  tumorale
chronique plutôt  que  de  chercher  à  enlever  une  « masse  tumorale  ». Le but  n’est  plus  d’effectuer  une  simple
« tumorectomie  », mais  la  résection  la  plus  large  possible  d’une  partie  du  cerveau  envahie  par  un GDBG,
à la condition  qu’elle  soit  fonctionnellement  non-cruciale.  Cette  nouvelle  philosophie  suggère  de  réaliser
une exérèse  maximaliste  et  précoce  selon  des  limites  fonctionnelles  (et  non  purement  oncologiques  ou
anatomiques) chez  des  patients  éveillés.  Cette  perspective  semble  représenter  la meilleure  voie  pour
construire une  «  neuro-oncologie  fonctionnelle  chirurgicale  »  personnalisée.
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Elsev. Introduction
Surgery for diffuse low-grade glioma (DLGG) was  debated for
 long time. This controversy was underlain by two  main ques-
ions: what is the actual impact of resection on the natural history
f DLGG?; what is the functional risk?
Here, the goal is to review the large amount of recent evidences
upporting a signiﬁcant role of surgery on overall survival (OS), by
elaying anaplastic transformation (AT) in DLGG patients, while
reserving or even improving the quality of life (QoL). Thanks to
onceptual advances in the understanding of dynamic relationships
etween DLGG progression and cerebral networks reorganization,
s well as thanks to methodological development in brain mapping
echniques, the beneﬁt-risk ratio of surgery dramatically increased
n the past decade [1]. Such an improvement of the onco-functional
alance of surgical resection should result in a paradigmatic shift
n DLGG, by switching from a traditional “wait and see” attitude
owards an early and maximal surgery based on functional-mapped
uided resection. Moreover, a multistage surgical approach inte-
rated in a personalized multimodal therapeutic strategy should
e more systematically considered [2].
. New insights into the natural course of diffuse low-grade
lioma (DLGG): tumor growth and brain plasticity
.1. Tumor growth
Contrary  to what was claimed in the classical literature, there is
o stable DLGG. Objective calculation of growth rate (based on at
east two magnetic resonance imaging [MRI] spaced by 3 months
efore any treatment) showed that all DLGG had a constant growth
uring their pre-malignant phase, with a linear increase of the
ean diameter (computed from the volume) around 4 mm  a year
3]. This growth was observed not only in symptomatic patients,
ut also in incidentally discovered DLGG [4,5]. Thus, the concept
f “progression-free survival” does mean nothing — at least before
hemotherapy or radiotherapy — because the growth rate is sim-
lar before and after surgery in cases of incomplete resection [6].
urthermore, there is an inverse correlation between growth rates
nd survival in DLGG, showing that the mean velocity of diametric
xpansion is a better prognostic factor than the neuropathologi-
al examination performed according to the current World Health
rganization (WHO) classiﬁcation [7].
These tumors are migrating along the white matter tracts
U ﬁbers, association, projection and commissural pathways) [8].
hus, DLGG is not a “tumor mass”, but is, in fact, an inﬁltrating
hronic disease progressively invading the central nervous system,
specially the subcortical connectivity. Such a diffusion of glioma
ells may  induce cognitive disorders, probably due (at least partly)
© 2012o a “disconnection syndrome” [9].
Finally, DLGG will ineluctably become malignant. Such AT will
ead to functional deﬁcit with a worsening of QoL and ultimately to
eath. In two European Organization for Research and Treatmentof  Cancer (EORTC) randomized multicenter trials with more than
600 patients, in the subgroup of patients with a favorable progno-
stic score, the OS was 7.7 years — whereas the in the subgroup
of patients with a poor prognostic score, the OS was only 3.2
years [10,11]. Clinical (age, neurologic and cognitive status, Karnof-
sky Performance Status [KPS] score), radiological (tumor volume,
location and kinetics, metabolic parameters), pathological and
molecular factors are correlated with the risk of AT and OS [12–15].
These data show that DLGG cannot be considered any more as
a “benign” tumor, but as a precancerous disease.
2.2. Functional considerations in diffuse low-grade glioma
(DLGG) patients
DLGG  usually involves young adults who enjoy a normal life. Yet,
neurological deﬁcits are rare in patients with DLGG (usually diag-
nosed after inaugural seizures), even if these tumors are frequently
located within “eloquent areas” [16]. This is due to mechanisms
of cerebral plasticity, explained by the fact that DLGG is a slow-
growing tumor, giving many years to the brain for functional
remapping — with a recruitment of perilesional or remote areas
within the ipsilesional hemisphere and/or of contra-hemispheric
homologous areas [17–19]. The recent integration of these con-
cepts into the therapeutic strategy resulted in dramatic changes in
the management of DLGG patients, with an increase of surgical indi-
cations in functional areas classically considered as “unresectable”
[20,21].
Nonetheless, cognitive deﬁcits are often observed when objec-
tive cognitive assessments are performed at time of diagnosis,
despite a normal social and professional life, challenging the tra-
ditional view of “DLGG patients with a normal examination” [22].
Indeed, many DLGG patients experienced disorders of executive
functions, attention, concentration, working memory or emotion
[23,24]. Therefore, an extensive neuropsychological evaluation
should be performed in all cases.
In summary, although it was traditionally claimed that DLGG
was a “benign tumor involving patients with a normal life”, it is now
clearly demonstrated that tumor induces functional disturbances
and will progress to a higher grade of malignancy — thus leading to
severe deﬁcit and ultimately to death. Thus, one should deﬁnitely
move towards an early therapeutic management, to delay cognitive
decline as well as AT.
3.  The impact of surgical resection in diffuse low-grade
glioma (DLGG)
A  phase III randomized trial comparing early versus later irra-
diation demonstrated that early radiotherapy had no signiﬁcant
  ier  Masson  SAS.  Cet article est publié en Open Access sous licence CC BY-NC-ND.impact on OS [25]. Rather, irradiation may  generate delayed cogni-
tive disorders [26]. Therefore, because radiotherapy is not the ﬁrst
therapeutic option to consider in DLGG, the impact of surgery has
been more rigorously studied in the recent literature.
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Comprehensive reviews suggested that a more extensive
esection of DLGG was correlated with a more favorable OS [27,28].
n an analysis of 10 studies since 1990, Sanai and Berger showed
hat the OS changed from 61.1 to 90.5 months with a greater
xtent of resection (EOR) — i.e. gross-total versus subtotal resection,
espectively [29]. However, the main problem explaining discrep-
ncies in the classical literature is related to the fact that, in the vast
ajority of series, EOR was not objectively assessed on postopera-
ive MRI, but was based on the sole subjectivity of the surgeons
r on a single computed tomography scan, with no volume mea-
urement of the residue. Due to the invasive feature of DLGG, the
esidual tumor was doubtlessly underestimated in numerous stud-
es, resulting in erroneous conclusions about the beneﬁt of surgery.
n fact, T2/FLAIR-MRI is the only way to actually calculate the post-
urgical volume of (possible) residual tumor (Fig. 1).
.1.  The modern literature
In  all the recent series since 2005 based on an objective post-
perative evaluation of EOR on T2/FLAIR-MRI, a more aggressive
esection predicted a signiﬁcant improvement in OS compared
ith a simple debulking. These studies agreed with the fact that
hen no signal abnormality was visible on control MRI  (“complete
esection”), patients had a signiﬁcantly longer OS compared with
atients having any residual abnormality. In the series by Smith
t al. including 216 DLGG, after adjusting for the effects of age, KPS,
umor location and tumor subtype, EOR remained a signiﬁcant pre-
ictor of OS (hazard ratio [HR] = 0.972; 95% conﬁdence interval [CI],
.960 to 0.983; P < 0.001), with 8-year OS of 98% of patients with
omplete resection [30]. In 156 DLGG, Claus et al. reported that
atients who underwent incomplete resection were at 4.9 times
he risk of death relative to patients with total resection [31]. In
22 DLGG, Duffau et al. found a signiﬁcant correlation between
omplete resection and OS [32]. Yeh et al. also demonstrated that,
n multivariate analysis performed in a consecutive series with 93
LGG, EOR and postoperative KPS showed independent prognostic
igniﬁcance for OS rates [33]. McGirt et al. observed that gross-total
esection versus subtotal resection was independently associated
ith increased OS (HR: 0.36; 95% CI: 0.16–0.84; P = 0.017) [34]. In
30 DLGG studied by Ahmadi et al., extended surgery was shown
o signiﬁcantly prolong OS [35]. Schomas et al. also reported that,
n an experience with 314 DLGG patients, adverse prognostic fac-
ors for OS identiﬁed by multivariate analysis were tumor size 5 cm
r larger, presentation with sensory motor symptoms, pure astro-
ytoma histology, Kernohan grade 2, and patients undergoing less
han subtotal resection [36]. In 190 DLGG, Ius et al. demonstrated
hat patients with an EOR of 90% or greater had an estimated 5-year
S rate of 93%, those with EOR between 70% and 89% had a 5-year OS
ate of 84%, and those with EOR less than 70% had a 5-year OS rate of
1% (P < 0.001) [37]. Finally, the French Glioma Network published
he largest surgical series of DLGG even reported, showing with an
xperience of 1097 patients that EOR as well as the post-surgical
esidual volume were independent prognostic factors signiﬁcantly
ssociated with a longer OS [38].
Even in incomplete tumor removal, patients with a greater per-
entage of resection had a signiﬁcantly longer OS. The survival was
igniﬁcantly better with at least 90% EOR compared with less than
0% EOR, whereas EOR of at least 80% remained a signiﬁcant predic-
or of OS [30]. The postoperative tumor volume is also a predictor
f survival, with a signiﬁcantly longer OS when the residue is less
han 10 cm3 (“subtotal resection”) compared with more than 10
m3 (“partial resection”). In a subgroup of 122 DLGG patients who
nderwent surgery with intraoperative functional mapping, Duf-
au et al. showed that, with a median follow-up of 4 years, 20.6% of
atients with more than 10 cm3 of residue died, while only 8% ofie 59 (2013) 2–8
patients  with less than 10 cm3 of residue died — and that no patients
with complete resection died (P = 0.02) [32].
Such an impact on OS is due to the fact that surgery delayed his-
tological upgrading, because the volume of residual tumor serves
as a predictor of AT. In the series Smith et al., after adjusting for
the effects of age, KPS, tumor location and tumor subtype, EOR
remained a signiﬁcant predictor of malignant progression-free sur-
vival (HR = 0.983; 95% CI: 0.972 to 0.995; P = 0.005) [30]. In 191
consecutive DLGG patients, Chaichana et al. also showed that gross-
total resection was  an independent factor associated with AT (RR:
0.526, 95% CI: 0.221–1.007; P = 0.05) [39].
3.2. Towards a supra-total resection of diffuse low-grade glioma
(DLGG)
Biopsy  samples within and beyond MRI-deﬁned abnormali-
ties showed that conventional MRI  underestimated the actual
spatial extent of DLGG, since tumor cells were present around
the area of MRI  signal abnormalities, up to 20 mm [4,5]. There-
fore, a recent series reported that a “supra-total” resection — that
is, resection extending beyond the area of MR imaging signal
abnormalities — performed in 15 patients with a DLGG within “non-
eloquent” brain regions avoided AT with a mean follow-up of 35.7
months (range 6–135) [40]. This series was compared with a con-
trol group of 29 patients who had “only” complete resection for a
DLGG: AT was  observed in seven cases in the control group but in no
cases in the series of patients who  underwent supra-total resection
(P = 0.037). Furthermore, adjuvant treatment was  administrated in
10 patients in the control group while only one patient who  under-
went supracomplete resection had adjuvant treatment (P = 0.043).
However, four of 15 patients with supracomplete resection experi-
enced recurrence, probably due to the fact that it was not possible
to take at least 20 mm of margin all around the tumor in all patients
due to functional limitations. It means that the goal of supra-total
resection is to delay AT and the administration of adjuvant therapy,
without claiming to cure DLGG patients [40].
3.3. The value of re-operation(s)
Because  relapse is possible after total or even supra-total
resection, and because continuous growth of the residual tumor
is ineluctable after incomplete resection, the impact of a second
surgery was  investigated. In 40 patients re-operated for recur-
rent DLGG without other intervening therapy between surgeries,
Schmidt et al. showed that a gross-total resection was associated
with an increased time to repeated surgery [41]. In 130 DLGG,
Ahmadi et al. observed that extended resection for non-malignant
relapse (a total resection could be achieved in 53.1% of recurrent
tumors) prolonged the OS signiﬁcantly [35]. In the French Glioma
Network series, subsequent surgical resection was an independent
prognostic factor signiﬁcantly associated with a longer OS [38].
Martino et al. also reported a consecutive series of 19 patients
who underwent a second surgery for recurrent DLGG in eloquent
areas [42]. A total or subtotal resection was achieved in 73.7% of
patients during the re-operation, despite an involvement of func-
tional areas. Such “multistage surgical approach”, with an initial
maximal function-guided resection, followed by a period of several
years, and then a second surgery with optimization of EOR while
preserving QoL, is possible thanks to mechanisms of brain plastic-
ity induced both by the tumor (re)growth as well as by the ﬁrst
resection itself [43,44]. The median time between surgeries was
4.1 years and the median follow-up from initial diagnosis was 6.6
years with no death during this period. Thus, the authors suggested
to consider re-operation(s) in all recurrent DLGG. Nonetheless, due
to a high rate of AT histologically proven of 57.9% at re-operation,
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Fig. 1. A. Preoperative axial FLAIR-weighted MRI  showing a left frontal diffuse low-grade glioma (DLGG) incidentally discovered (headaches) in a young right-handed
adult with a normal neurological examination and enjoying a normal life. The preoperative neuropsychological examination demonstrated slight attentional disorders.
B. Intraoperative photograph. Left: view before resection showing the tumor limits (letter tags) identiﬁed by ultrasonography as well as the eloquent cortical structures
(number tags) detected by direct electrostimulation (DES). Right: view after glioma removal, performed according to functional boudaries — detected by DES both at cortical
and  subcortical levels throughout the resection (no neuronagivation, no intraoperative MRI). In other words, a functional-mapped guided resection was achieved, and not
an  image-guided resection. C. Postoperative axial FLAIR-weighted MRI, demonstrating a resection of the DLGG (histologically conﬁrmed), including its part involving the so-
called  “Broca’s area” as well as within the corpus callosum. Despite an extensive left frontal lobectomy, the patient recovered, and returned to normal social and professional
lives (full-working) 3 months after surgery, with no symptoms. Interestingly, there was an improvement of the objective cognitive assessment performed 3 months following
the  resection in comparison with the pre-surgical evaluation, thanks to a speciﬁc cognitive rehabilitation. No antiepileptic drugs and no adjuvant oncological treatments
were given.
A.  IRM préopératoire, coupe axiale, pondération FLAIR, qui montre un gliome de bas grade, diffuse, frontal gauche, de découverte fortuite (céphalées), chez un jeune adulte droitier
présentant un examen neurologique normal et menant une vie normale. Le bilan neuropsychologique préopératoire a objectivé quelques troubles modérés de l’attention. B. Photogra-
phies  peropératoires. À gauche : vue avant la résection, montrant les limites de la tumeur (étiquettes avec lettres) identiﬁées par échographie, de même que les structures corticales
fonctionnelles (étiquettes avec chiffres) détectées par stimulations électriques directes. À droite : vue après la résection du gliome, effectuée selon des limites fonctionnelles – détectées
par  stimulations électriques peropératoires à la fois en cortical et sous-cortical tout au long de l’exérèse (pas de neuronavigation, pas d’IRM peropératoire). En d’autres termes, il
s’agit  d’une résection guidée par la cartographie fonctionnelle et non par l’image. C. IRM postopératoire, coupe axiale, pondération FLAIR, qui montre la résection d’un gliome de bas
grade  diffus (conﬁrmé par l’histologie) incluant une partie impliquant la région dite « de Broca », de même que le corps calleux. En dépit d’une lobectomie frontale gauche étendue, le
p in tem
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D
tatient  a récupéré et a repris une vie sociale et professionnelle normale (travaille à ple
u’une amélioration cognitive a été mise en évidence sur un bilan objectif effectué trois
ne  rééducation spéciﬁque. Aucun traitement n’a été donné, ni antiépileptique, ni oncol
t was proposed to “over indicate” an early re-intervention
ather  than to perform a late surgery when AT already occurred
42].
.4. The limited role of biopsy in diffuse low-grade glioma (DLGG)Currently, the indications of biopsy are very limited in
LGG. Indeed, by combining clinical and radiological data,
he diagnosis of glioma is typical in the vast majority ofps), trois mois après l’intervention, sans symptôme résiduel. Il est intéressant de noter
après l’exérèse, en comparaison par rapport à l’évaluation préopératoire, et ce, grâce à
e adjuvant.
cases.  Thus, the main goal of neuropathological examina-
tion is to give the actual grade of the glioma. However,
there is a high risk of sampling error. Muragaki demon-
strated that overgrading of WHO  grade I gliomas occurred
in 11% of cases and undergrading of WHO  grade III gliomas
in 28% [45]. Conversely, maximal DLGG resection pro-
vides a more extensive amount of tumoral tissue, and thus
increases the reliability of the histological diagnosis and
grading [28].
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Furthermore, biopsy has no therapeutic impact. Therefore,
ecause the risk of MR-guided stereotactic biopsies is still around
% of permanent deﬁcits [46], their indications for presumed DLGG
re essentially contraindications of surgery. Beyond patients who
on’t want or who are not able to undergo surgical resection for
edical reasons, biopsy can be mainly considered in diffuse lesions,
uch as gliomatosis, or when a subtotal resection is not a pri-
ri possible. Such a pre-surgical prediction can be optimized by
he use of a probabilistic map  of postoperative residue, based on
he computation of residual gliomas resected according to func-
ional boundaries: this atlas allows a preoperative estimation of
he expected EOR with a success rate of 82% [47].
. Functional considerations: awake surgery for maximal
esection of diffuse low-grade glioma (DLGG)
.1. The conceptual shift from an image-guided surgery towards
 functional mapping-guided resection
Based on these strong oncological results, brain surgeons should
hange their mind, by operating the nervous system involved by
 chronic tumoral disease — and no more by operating a “tumor
ass” [21]. The goal is not to content with a single “tumorectomy”,
.e. removal of the part of the tumor visible on imaging, but to per-
orm the most extensive resection of the brain invaded by DLGG,
n the condition that this part of the brain is not crucial for cerebral
unctions. Thus, neurosurgeon should adapt his surgical procedure
o the individual cerebral anatomo-functional organization. The
echnique within the central nervous system has to be different
rom the surgical technique outside the brain. Indeed, the ﬁrst prin-
iple in glioma surgery should be to tailor the resection according
o functional boundaries, with no margin, to maximize the tumor
emoval while preserving eloquent structures [44].
The  methods of intrasurgical imaging (neuro-navigation, intra-
perative MRI) suffer from serious limitations. First, from an
ncological point of view, conventional T2/FLAIR-MRI does not
how the whole tumoral disease but only the top of the iceberg.
ndeed, tumors appear on MRI  only for cell densities above 500
ells/mm3 [48]. Therefore, when DLGG is distant from eloquent
tructures, image-guided resection is by deﬁnition a non-sense.
ndeed, it is possible in these speciﬁc cases to remove more tumoral
ells while preserving the function, i.e. to perform a “supra-total”
esection, with the impact on AT detailed above, on the condition
evertheless to not constraint the resection according to the MRI
40]. The use of neuro-navigation or intraoperative MRI is based
n a reductionist concept, that is, the exclusive removal of the sig-
al abnormality, with no attempt to increase the resection beyond
hese landmarks — even if they do not reﬂect the whole glioma dis-
ase. Consequently, image-guided resection may  represent a loss
f chance for patients with a DLGG outside critical regions [9].
From  a functional point of view, due to a great interindividual
natomo-functional variability, even though anatomical landmarks
emain essential during cerebral surgery, they are deﬁnitely not
nough. The aim is to continue the removal of the brain invaded
y DLGG until crucial eloquent structures have been encountered,
oth at cortical and subcortical levels, with no margin around
hese functional boundaries [49]. Neurosurgeons have tendency
o believe that the data provided by functional MRI  and diffusion
ensor imaging are the “absolute truth”. Yet, functional neuroimag-
ng is based on biomathetical reconstruction, with results which
ay change according to the model, explaining its lack of reliabil-ty at the individual level, especially regarding cognitive functions
uch as language [50,51]. Furthermore, neuroimaging is not able to
ifferentiate areas crucial for brain functions from regions which
ould be functionnally compensated. Thus, there is a double risk: toie 59 (2013) 2–8
not  select a patient for DLGG surgery because fMRI activations are
visible very near or within the tumor, while it was in fact possible
to remove it with no permanent deﬁcit (thus with a loose of chance
from an oncological point of view); or to induce a permanent deﬁcit
due to a false negative.
4.2.  Cortico-subcortical mapping using direct electrostimulation
(DES): a major role to improve the onco-functional balance of
surgery
Intraoperative electrostimulation mapping in awake patient is
actually the more reliable method to identify eloquent regions.
The goal here is not to detail the methodology of direct elec-
trostimulation (DES), which was  extensively described in previous
reports [52,53]. This is an easy, safe, non-expensive, reliable and
reproducible technique allowing the identiﬁcation of crucial (non-
functionally compensable) structures at the level of the cortex,
white matter pathways and deep gray nuclei — and thus to per-
form real-time anatomo-functional correlations throughout the
resection [54].
In  the past decade, brain mapping has led to an impressive
improvement of both functional and oncological outcomes in
DLGG surgery. First, patients who  were classically not selected
for surgery, on the basis of pure anatomical criteria (e.g. gliomas
involving the “Broca’s area”), can now beneﬁt from resection with
no dogmatic a priori against the surgical feasibility due to tumor
location. The use of intrasurgical DES allowed a signiﬁcant increase
of the surgical indications for DLGG involving so-called “eloquent
areas”, when compared with a control group of patients who under-
went resection under general anesthesia with no mapping [32]. For
example, surgical resection is possible with no permanent neuro-
logical worsening for DLGG within Broca’s area, Wernicke’s area,
insula, left dominant inferior parietal lobule, retrocentral area and
even the precentral region [20,44,52].
Furthermore, the rate of permanent neurological deﬁcits was
shown to be signiﬁcantly lesser thanks to awake mapping, i.e. less
than 2% in the recent series using DES [54,55]. This rate is very
reproducible among the teams using awake mapping worldwide.
Indeed, a recent meta-analysis studying more than 8000 patients
who underwent surgical resection for a brain glioma demonstrated
that the use of intrasurgical mapping allowed a statistically signif-
icant reduction of permanent deﬁcit, despite an increased rate of
resection within eloquent areas [56].
This meta-analysis also showed that EOR was  increased [56].
This is in line with a recent series in which 9 patients under-
went two  consecutive surgeries for a DLGG: the ﬁrst resection
was performed in a traditional way, that is, under general anes-
thesia and without mapping, whereas the subsequent surgery was
done in a maximal way, in awake patients using DES. Following
the re-operation, postoperative MRI  showed that the resection was
improved in all cases compared with the ﬁrst surgery (P = 0.04),
with no permanent neurological worsening [57]. Finally, a series
of 281 patients demonstrated that the use of functional mapping-
guided resection of DLGG in presumed eloquent areas, thanks to a
reliable delineation of true functional and nonfunctional regions,
allowed not only a maximization of EOR but also a signiﬁcant
improvement of OS [58].
5.  Conclusion
Currently, as stated by the European guidelines, surgery is the
ﬁrst therapeutic option in DLGG patients [59]. Because DLGG is a
diffuse brain disease, which frequently invades eloquent regions,
neurosurgeons should take the habit to see the brain ﬁrst, and not
the tumor, by performing early and maximal resection according
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o functional (and not purely oncological or anatomical) bound-
ries in awake patients. This perspective seems to represent the
est way to build a modern and personalized “functional surgical
euro-oncology”. The next step will be to evolve towards “preven-
ive neurosurgery” by achieving removal of incidentally discovered
LGG in asymptomatic patients [60].
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